SAVINO, Rocco
 Distribuzione geografica
Continente #
NA - Nord America 2.587
AS - Asia 1.168
EU - Europa 774
SA - Sud America 199
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 4.759
Nazione #
US - Stati Uniti d'America 2.488
SG - Singapore 634
CN - Cina 368
IT - Italia 354
BR - Brasile 155
SE - Svezia 118
DE - Germania 101
CA - Canada 84
GB - Regno Unito 83
VN - Vietnam 61
IN - India 34
FI - Finlandia 32
HK - Hong Kong 16
PL - Polonia 15
AR - Argentina 14
ES - Italia 14
ZA - Sudafrica 11
BD - Bangladesh 10
CZ - Repubblica Ceca 10
JP - Giappone 10
TR - Turchia 10
EC - Ecuador 9
MX - Messico 9
CL - Cile 7
RO - Romania 7
UA - Ucraina 7
EU - Europa 6
FR - Francia 6
AT - Austria 5
AU - Australia 5
ID - Indonesia 4
IR - Iran 4
NL - Olanda 4
PY - Paraguay 4
RU - Federazione Russa 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
KE - Kenya 3
CO - Colombia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
HN - Honduras 2
IE - Irlanda 2
IL - Israele 2
LT - Lituania 2
MA - Marocco 2
PE - Perù 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
EG - Egitto 1
GM - Gambi 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
IQ - Iraq 1
JO - Giordania 1
KI - Kiribati 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MW - Malawi 1
MY - Malesia 1
NO - Norvegia 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
Totale 4.759
Città #
Dallas 485
Chandler 357
Singapore 249
Santa Clara 154
Hefei 142
Milan 134
Princeton 134
Lawrence 130
Ashburn 94
Wilmington 79
Catanzaro 70
Ottawa 67
Munich 63
London 54
Chicago 52
Boardman 48
Des Moines 41
Shanghai 30
Turku 29
Troina 27
Guangzhou 23
New York 22
Beijing 21
Ho Chi Minh City 21
Los Angeles 18
The Dalles 18
Columbus 17
Seattle 16
São Paulo 16
Hong Kong 15
Norwalk 15
Warsaw 15
Council Bluffs 14
Naples 13
Florence 12
San Francisco 12
Wuhan 12
Falls Church 11
Pune 11
Boston 10
Brooklyn 10
Olomouc 9
Redmond 9
Tokyo 9
Cicciano 8
Hanoi 8
Rome 8
Atlanta 7
Rio de Janeiro 7
Shenzhen 7
Ann Arbor 6
Hanover 6
Johannesburg 6
Phoenix 6
Charlotte 5
Haiphong 5
Jiaxing 5
New Delhi 5
Parenti 5
Quito 5
Redwood City 5
Washington 5
Belo Horizonte 4
Chennai 4
Curitiba 4
Denver 4
Girona 4
Guayaquil 4
Horia 4
Manchester 4
Mountain View 4
Porto Alegre 4
Stockholm 4
Toronto 4
West Jordan 4
Amsterdam 3
Ankara 3
Brasília 3
Campinas 3
Helsinki 3
Louisville 3
Montevideo 3
Montreal 3
Nairobi 3
Palermo 3
Philadelphia 3
Rui'an 3
Salvador 3
Vibo Valentia 3
Andover 2
Aracaju 2
Assago 2
Birmingham 2
Buffalo 2
Bắc Ninh 2
Campbelltown 2
Can Tho 2
Cape Town 2
Da Nang 2
Delhi 2
Totale 3.013
Nome #
Untargeted metabolomics fingerprints in seminal plasma of patients with abnormal sperm morphology using high-performance liquid chromatography and mass spectrometry 173
An Analytical Method for Assessing Optimal Storage Conditions of Gingival Crevicular Fluid and Disclosing a Peptide Biomarker Signature of Gingivitis by MALDI-TOF MS 74
An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 72
Effects of budesonide on p38 MAPK activation, apoptosis and IL-8 secretion, induced by TNF-α and Haemophilus influenzae in human bronchial epithelial cells 71
Application of proteomics and peptidomics to COPD 64
A METHODOLOGY FOR SELECTING SUPERAGONISTS, ANTAGONISTS AND SUPERANTAGONISTS OF HORMONES WHOSE RECEPTOR COMPLEX INCLUDES GP 130 62
ADENOVIRAL VECTORS ENCODING ERYTHROPOIETIN AND THEIR USE IN GENE THERAPY 59
Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung 57
Mesopore-assisted Profiling of Human Synovial Fluid 57
Asthma and COPD proteomics: Current approaches and future directions 57
Biological mechanisms underlying the clinical effects of allergen-specific immunotherapy in asthmatic children 57
An alternative approach for the identification of potential prostate cancer biomarkers 57
277 POSTER An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 55
Rapid detection and identification of antimicrobial peptide fingerprints of nasal fluid by mesoporous silica particles and MALDI-TOF/TOF mass spectrometry: from the analytical approach to the diagnostic applicability in precision medicine 53
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 53
A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent 51
Assessment of pre-analytical and analytical variables affecting peptidome profiling of gingival crevicular fluid by MALDI-TOF mass spectrometry 50
A PARADIGM SHIFT FOR ERYTHROPOIETIN: NO LONGER A SPECIALIZED GROWTH FACTOR, BUT RATHER THAN AN ALL-PURPOSE TISSUE-PROTECTIVE AGENT 50
A fast and sensitive colorimetric assay for IL-6 in hepatoma cells based on the production of a secreted form of alkaline phsphatase (SEAP) 49
A rapid and reproducible standardized procedure for MALDI-TOF profiling of gingival crevicular fluid 49
Adenovirus-mediated gene transfer of a human IL-6 antagonist 49
Associazione di antagonisti di IL-6 e farmaci anti-proliferativi (depositato il 10.3.2005 n. RM2005A000103) 49
MALDI MS-Based Investigations Targeting SARS-CoV-2 49
Biochemical modification of an Interleukin-6 antagonist to target myeloma cells in the bone marrow microenvironment 48
Hexagonal Mesoporous Silica as a Rapid, Efficient and Versatile Tool for MALDI-TOF MS Sample Preparation in Clinical Peptidomics Analysis: A Pilot Study. 48
Objective and self-evaluation voice analysis after transoral laser cordectomy and radiotherapy in T1a-T1b glottic cancer 47
ADENOVIRAL VECTORS FOR MUTANTS OF HUMAN INTERLEUKIN 6 (HIL-6) WITH HIL-6 ANTAGONIST ACTIVITY, PHARMACEUTICAL COMPOSITIONS THEREWITH AND THEIR USES 46
An improved helper-dependent adenoviral vector allows persistent gene expression after i.m. delivery and overcomes pre-existing immunity to adenovirus 45
Application of MSB-MALDI-TOF-MS Technology to body fluids and Tissues peptidome profiling 45
A rapid differential display analysis of nasal swab fingerprints to distinguish allergic from non-allergic rhinitis subjects by mesoporous silica particles and MALDI-TOF mass spectrometry 45
The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial 44
Enhancing plasma peptide MALDI-TOF-MS profiling by mesoporous silica assisted crystallization 44
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases 43
Influence of storage conditions on MALDI-TOF MS profiling of gingival crevicular fluid: Implications on the role of S100A8 and S100A9 for clinical and proteomic based diagnostic investigations 43
Integrating peptidomic with lipidomic fingerprints by using mesoporous aluminosilicate and MALDI-TOF MS 43
Characteristics and clinical implications of the pharmacokinetic profile of ibuprofen in patients with knee osteoarthritis 43
Biologics in severe asthma 43
Effect of a novel functional tomato sauce (OsteoCol) from vine-ripened tomatoes on serum lipids in individuals with common hypercholesterolemia: tomato sauce and hypercholesterolemia 43
Effects of statins and farnesyl transferase inhibitors on ERK phosphorylation, apoptosis and cell viability in non small lung cancer cells. 42
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach 42
Two distinct and independent sites on IL-6 trigger gp130 dimer formation and signalling 41
Association between low bone mineral density and increased α-defensin in salivary fluid among postmenopausal women 41
A mass spectrometry-based proteomic approach for the identification and quantification of potential biomarkers in prostate cancer. 40
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for biomarker discovery of Asthma and COPD 40
Mass Spectrometry-Based Untargeted Approaches to Reveal Diagnostic Signatures of Male Infertility in Seminal Plasma: A New Laboratory Perspective for the Clinical Management of Infertility? 39
TLR4 triggered complex inflammation in human pancreatic islets 38
A ROLE FOR U3 SMALL NUCLEAR RIBONUCLEOPROTEIN IN THE NUCLEOLUS 38
Peptidomic analysis of induced sputum of asthmatic patients by MSB-MALDI-TOF-MS platform 38
ANTAGONISTS OF HUMAN INTERLEUKIN-6 THAT ARE TOTALLY INCAPABLE OF BINDING GP 130, AND THEIR USE IN THE PREPARATION OF PHARMACEUTICAL COMPOUNDS 38
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide 38
Gingival Crevicular Fluid Peptidome Profiling in Healthy and in Periodontal Diseases. 37
Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study 37
Effects of Ambrisentan in a Patient Affected by Combined Pulmonary Fibrosis and Emphysema and by Severe Pulmonary Hypertension: Clinical, Functional, and Biomolecular Findings 36
Mesopore-assisted fingerprints of gingival crevicular fluid by MALDI-TOF mass spectrometry for monitoring inflammatory state in patients wearing fixed orthodontic appliance 36
Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts 36
The molecular design of human IL-6 receptor antagonists 35
PRERIBOSOMAL RNA PROCESSING IN XENOPUS-OOCYTES DOES NOT INCLUDE CLEAVAGE WITHIN THE EXTERNAL TRANSCRIBED SPACER AS AN EARLY STEP 35
Mapping the SARS-CoV-2–host protein–protein interactome by affinity purification mass spectrometry and proximity-dependent biotin labeling: A rational and straightforward route to discover host-directed anti-SARS-CoV-2 therapeutics 35
Liposomal Delivery Improves the Growth Inhibitory and Apoptotic Activity of Low Doses of Gemcitabine in Multiple Myeloma Cancer Cells 35
Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone 34
MUTANT INTERLEUKIN 6 WITH IMPROVED BIOLOGICAL ACTIVITY OVER WILD INTERLEUKIN 6 34
Involvement of the Arg179 in the active site of human IL-6 34
Cell cycle regulation and induction of apoptosis by IL-6 variants on the multiple myeloma cell line XG-1 33
Generation of IL-6 antagonists by substituting residues in helix A 33
Liquid Cristalline Phases for the Ophthalmic Administration of Drug 33
Simvastatin Action Is Not Related to HDAC2 Expression in Non-Small Cell Lung Cancer (NSCLC) 33
An integrated metabo-lipidomics profile of induced sputum for the identification of novel biomarkers in the differential diagnosis of asthma and COPD 32
EXTRA-RIBOSOMAL SPACER SEQUENCES IN TRITURUS 32
REGULATION OF U3 SNRNA GENE-EXPRESSION 32
Effect of IL-6 variants in Multiple Myeloma:growth inhibition and induction of apoptosis in primary cells 32
Mesoporous Beads: New Tools and Strategies in Body Fluids Proteomics 32
Identification of Novel Angiogenic Proteins in Multiple Myeloma Patient-Derived Endothelial Cells Using Proteome-Wide Analysis 32
C3f is a potential tool for the staging of osteoarthritis 32
Monovalent phage display of human Interleukin (hIL)-6: selection of superbinder variants from a complex molecular repertoire in hIL-6 D-helix 32
test di Valutazione di efficacia dei chemioterapici effettuato su tre distinte e complementari popolazioni cellulari derivate dalla massa tumorale solida 31
Revealing the Hidden Diagnostic Clues of Male Infertility from Human Seminal Plasma by Dispersive Solid Phase Extraction and MALDI-TOF MS 31
Targeted proteomic approach in prostatic tissue: a panel of potential biomarkers for cancer detection 31
ANTI-TUMOUR PHARMACEUTICAL COMPOSITIONS CAPABLE OF REDUCING DRUG RESISTANCE IN TUMOUR CELLS 31
Peptidome profiling of gingival crevicular fluid by MALDI-TOF/TOF mass spectrometry 31
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells 31
Identification of residues critical for biological activity and receptor binding of human Interleukin-6 30
Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu in vivo model of human multiple myeloma 30
Treatment with an adenoviral vector expressing the IL-6 receptor superantagonist sant7 compared with the treatment with the recombinant sant7 protein in MM cell lines 29
Effects of simvastatin and rosuvastatin on RAS protein, matrix metalloproteinases and NF-kappa B in lung cancer and in normal pulmonary tissues 29
An improved helper-dependent adenoviral vector allows persistent gene expression after intramuscular delivery and overcomes preexisting immunity to adenovirus 29
Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death 28
Definition of a complex binding site for gp130 in human interleukin-6 (IL-6) 27
In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6-transgenic mice with a hIL-6 receptor antagonist 27
Testosterone replacement therapy in insulin-sensitive hypogonadal men restores phosphatidylcholine levels by regulation of arachidonic acid metabolism 27
Designing new agonists/antagonists of growth factor receptors- The rational design of a super-antagonist of the IL-6 receptor 26
MALDI-TOF MS ANALYSIS OF LOW-ABUNDANCE PEPTIDE ENRICHED FROM BODY FLUIDS BY MESOPOROUS SILICA BEADS 26
Derivatized Mesoporous Silica Beads for MALDI-TOF MS Profiling of Human Plasma and Urine 26
Combination of Interleukin-6 antagonists and antiproliferative drugs 25
Inhibitory effects of the IL-6 receptor superantagonist SANT7 on MAP kinase phosphorylation and cell proliferation induced by IL-6 and TGF-beta1in human lung fibroblasts 25
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets 25
Functionalized Mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine 24
Role of p38 mitogen-activated protein kinase in asthma and COPD: Pathogenic aspects and potential targeted therapies 24
MALDI MS-Based Investigations for SARS-CoV-2 Detection 24
Generation of interleukin-6 receptor antagonists by molecular-modeling guided mutagenesis of residues important for gp130 activation 23
Severe Eosinophilic Asthma: from the Pathogenic role of Interleukin-5 to the Therapeutic Action of Mepolizumab. 23
Totale 4.087
Categoria #
all - tutte 59.554
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.554


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 1 3 7 2 3 5 136 8 0 6
2021/2022362 2 0 10 90 37 10 17 78 30 32 55 1
2022/20231.070 267 45 50 76 117 132 5 60 169 44 83 22
2023/2024420 63 59 54 22 26 100 4 24 5 7 11 45
2024/20251.527 216 140 77 87 122 167 5 29 183 125 143 233
2025/20261.188 172 365 651 0 0 0 0 0 0 0 0 0
Totale 4.860